cell cycle orignal date по junhong dong (22092350)

Предметы:

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers по Juliana Navarro-Yepes (17079059)

Предметы:

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Comp... по Michael D. Nyquist (16918265)

Предметы:

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Comple... по Michael D. Nyquist (16918265)

Предметы:

Figure S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Figure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Supplementary Data 1 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer по Hong Qiu (14963144)

Предметы:

Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer по Hong Qiu (14963144)

Предметы:

Figure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Figure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Figure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Figure S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity по Shiyi Yu (17079079)

Предметы:

Table S1 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... по Xiaoqing Cheng (16918496)

Предметы:

Table S5 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... по Xiaoqing Cheng (16918496)

Предметы:

Table S6 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... по Xiaoqing Cheng (16918496)

Предметы:

Table S2 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... по Xiaoqing Cheng (16918496)

Предметы:

Table S3 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... по Xiaoqing Cheng (16918496)

Предметы:

Table S4 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... по Xiaoqing Cheng (16918496)

Предметы: